← Open Payments lookup

JENNIFER WRUCK: Open Payments

NPI 1144998204 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$487 in 25 payments from 9 companies in 2025. Trend: 2023 $851 · 2024 $1,484 · 2025 $487

Food & beverage: $487
CompanyPaymentsAmount
Gilead Sciences, Inc.9$194
ABBVIE INC.9$144
Madrigal Pharmaceuticals1$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Intercept Pharmaceuticals, Inc.1$22
Amgen Inc.1$20
Fujifilm Healthcare Americas Corporation1$20
Eton Pharmaceuticals, Inc.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: MAVYRET, REZDIFFRA, XIFAXAN, OCALIVA, UPLIZNA, UTASWAKO AFP-L3, GALZIN, GATTEX.

Industry payments across TX — which companies pay providers there.